Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 mutations
Objectives. To assess the cancer risk profile in BRCA-mutation-positive and negative South African breast-ovarian cancer families, mainly of Caucasian origin.
Design. Descriptive study in which the prevalence of all cancers in the pedigrees of BRCA1- and BRCA2-mutation-positive groups and a group of families without mutations in either gene were compared with the general population.
Results. As expected, female breast and ovarian cancer was significantly increased in all three groups. Furthermore, male breast cancer was significantly elevated in the BRCA2-positive and BRCA-negative groups. Stomach cancer prevalence was significantly elevated in the BRCA2-positive families compared with the general population.
Conclusions. These results can be applied in estimation of cancer risks and may contribute to more comprehensive counselling of mutation-positive Caucasian breast and/or ovarian cancer families.
C M Schlebusch, Cancer Genetics, Department of Genetics, University of Pretoria
G Dreyer, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Pretoria
M D Sluiter, Cancer Genetics, Department of Genetics, University of Pretoria
T M Yawitch, Cancer Genetics, Department of Genetics, University of Pretoria
H J van den Berg, Department of Health, Gauteng Provincial Administration
E J van Rensburg, Cancer Genetics, Department of Genetics, University of Pretoria
Full TextPDF (225KB)
Cite this article
Date published: 2010-01-29
Full text views: 1243